{"id":"W2527243486","doi":"10.1016/j.jaad.2016.07.040","title":"Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Dermatology Life Quality Index; Placebo; Psoriasis; Janus kinase inhibitor; Quality of life (healthcare); Randomized controlled trial; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Dermatology; Rheumatoid arthritis; Alternative medicine; Pathology; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021478,0.001601758,0.003434911,0.0004940329,0.0004866745,0.00130118,0.0007776335,0.001684948,0.005269698],"category_scores_gemma":[0.001821929,0.0006049798,0.004139368,0.0005761393,0.0008860239,0.001230998,0.0003658778,0.003793225,0.000605716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001027913,"about_ca_system_score_gemma":0.0007302114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00124326,"about_ca_topic_score_gemma":0.003908111,"domain_scores_codex":[0.9993711,0.0002624696,0.00005038983,0.0001135564,0.00006704368,0.000135471],"domain_scores_gemma":[0.9991399,0.0002997641,0.0002478211,0.00005186653,0.00006102938,0.0001995372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8777711,0.006599869,0.002399796,0.003156368,0.006240007,0.0001262323,0.0001358598,0.0008572632,0.006506483,0.0001911074,0.00343584,0.09258001],"study_design_scores_gemma":[0.9455365,0.04259939,0.006643071,0.0001575892,0.002351758,0.0001367628,0.00004481254,0.0003027673,0.0005211615,0.0001926181,0.001486772,0.00002674715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9391355,0.04855822,0.0007810183,0.001848691,0.0007079389,0.001880945,0.00223111,0.0002048934,0.004651733],"genre_scores_gemma":[0.973357,0.01735948,0.001269873,0.001868512,0.0005699617,0.001356865,0.002046352,0.00004077952,0.002131176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005269698,"threshold_uncertainty_score":0.01762891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03777943338510351,"score_gpt":0.3214798812904353,"score_spread":0.2837004479053318,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}